›Edge flaring to reduce skin pressure
›Post application checks
›Motor function toes
›Great toe extension
›Toe flexion
›Sensation
›Dorsum and plantar surfaces
›First web space
›Perfusion
›Cap refill
›Distal pulses
›Reduction indications
›Calcaneocuboid dislocation or gross subluxation
›Visible deformity
›Neurovascular compromise
›Threatened skin from bony prominence
›Skin blanching
›Tenting
›Analgesia and anesthesia options
›Non opioid baseline
›Acetaminophen PO 1000 mg
›Ibuprofen PO 400-600 mg
›Opioid for severe pain
›Morphine IV 0.05-0.1 mg/kg
›Hydromorphone IV 0.01-0.015 mg/kg
›Regional anesthesia
›Ankle block approach
›Posterior tibial nerve block
›Deep peroneal nerve block
›Superficial peroneal nerve block
›Sural nerve block
›Procedural sedation when needed
›Monitoring requirements
›Continuous pulse oximetry
›Continuous ECG
›Capnography when available (ACEP Level B)
›Medication options
›Ketamine IV 1 mg/kg
›Additional 0.25-0.5 mg/kg PRN q5-10 min
›Propofol IV 0.5-1 mg/kg
›Additional 0.25-0.5 mg/kg PRN q2-3 min
›Technique principles
›Traction and countertraction
›Forefoot traction
›Hindfoot stabilization
›Reverse deforming force
›If forefoot abducted, gentle adduction
›If lateral subluxation, medial translation
›Gentle sustained pressure
›Avoid repeated forceful attempts
›Stop if increasing neurovascular compromise
›Post reduction requirements
›Immediate neurovascular reassessment
›Pulses and cap refill
›Sensation change
›Post reduction imaging
›Foot series confirmation
›Joint congruity confirmation
›Immobilization in stable position
›Posterior short leg plus stirrup if unstable
›Strict non weight bearing
›Failed reduction pathway
›If irreducible, urgent orthopedics
›CT for interposed fragments
›OR reduction planning
›If persistent neurovascular deficit, emergent escalation
›CTA consideration
›Vascular consultation
Open fracture medications and timing
›Antibiotic pathway summary
›Timing target
›Within 60 minutes of recognition (Class I)
›Document time given
›First line closed chain context
›Cefazolin IV 2 g q8h
›Duration per ortho plan
›Allergy alternative
›Clindamycin IV 900 mg q8h
›Vancomycin per local MRSA protocol when indicated
›Tetanus pathway summary
›Clean minor wound
›Tdap if >10 years since last dose
›No TIG if immunized
›Dirty or high risk wound
›Tdap if >5 years since last dose
›TIG if incomplete immunization
DVT prophylaxis when relevant
›Risk stratification
›Lower limb immobilization with additional risk factors
›Prior VTE
›Active cancer
›Surgical pathway planned
›Ortho protocol driven
›Shared decision documentation
›Contraindication screen
›Active bleeding
›Severe thrombocytopenia